Skip to main navigation
Skip to search
Skip to main content
The Hebrew University of Jerusalem Home
Approve / Request updates on publications
Link opens in a new tab
Search content at The Hebrew University of Jerusalem
Home
Profiles
Research units
Research output
Prizes
The two facets of gp130 signalling in liver tumorigenesis
Dirk Schmidt-Arras
*
,
Eithan Galun
*
, Stefan Rose-John
*
*
Corresponding author for this work
Institute for Medical Research Israel-Canada (IMRIC)
Research output
:
Contribution to journal
›
Review article
›
peer-review
16
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The two facets of gp130 signalling in liver tumorigenesis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Glycoprotein 130 (gp130)
100%
Liver Tumorigenesis
100%
Liver
50%
Signaling Molecules
25%
Tumor Cells
25%
Cancer Causes
25%
Cancer Mortality
25%
Inflammatory Mediators
25%
Tumor Microenvironment
25%
Liver Tumor
25%
Hepatic Tumorigenesis
25%
Receptor Subunits
25%
Regenerability
25%
Downstream Signaling
25%
Multiple Functions
25%
IL-6 Cytokine
25%
Vital Organs
25%
Therapeutic Interventions
25%
Medicine and Dentistry
Carcinogenesis
100%
Glycoprotein Gp 130
100%
Malignant Neoplasm
25%
Cytokine
25%
Tumor Cell
25%
Mediator
25%
Tumor Microenvironment
25%
Interleukin 6
25%
Signaling Molecule
25%
Drive
25%
Receptor Subunit
25%
Tumor
25%
Inflammation
25%
Pharmacology, Toxicology and Pharmaceutical Science
Carcinogenesis
100%
Glycoprotein Gp 130
100%
Inflammation
25%
Cytokine
25%
Receptor Subunit
25%
Malignant Neoplasm
25%
Tumor Microenvironment
25%
Interleukin 6
25%
Biochemistry, Genetics and Molecular Biology
STAT3
100%
Carcinogenesis
100%
Drive
33%
Mediator
33%
Interleukin 6
33%
Cytokine
33%